Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
about
The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic reviewPreliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso.Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania.Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda.Malaria: an update on current chemotherapy.Treating severe malaria in pregnancy: a review of the evidenceModelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesMass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination.Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implicationsAssessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique.A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients.Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers.Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda.Obstetric Pharmacokinetic Dosing Studies are Urgently Needed.Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action.Treatment regimens for pregnant women with falciparum malaria.Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis.Population pharmacokinetics of artemether, dihydroartemisinin and lumefantrine in Rwandese pregnant women treated for uncomplicated malariaMalaria in pregnancy
P2860
Q28079877-9118D447-44DC-470F-9B4C-479306B60240Q33710687-C40FF7DC-F6D2-41DA-88DF-A745E7B8988FQ34034413-E74AB71E-F63A-4344-BEFA-55C7C2BF6DFBQ34058351-07179C47-0C43-4226-81F0-58779E89D4DBQ34331026-08FACC28-66E4-4ABD-A247-8ED667F9EFE6Q34433106-BFAC3342-0D85-4966-80A5-68A20FD8BF27Q34456393-AF75ED42-92DF-4822-8227-675D33361D6AQ34953705-7D22C165-14AE-4AB9-994B-D1DDBFAA3DF1Q35224221-1B0B4BA7-8610-4154-BC57-AF5B6233C6AAQ35286119-CC8B8E26-D76A-4A5E-BF9D-5D92317F2C63Q36348696-2F0D3519-DB03-4E41-A7DA-D439F49B9C5FQ36552289-EC7E3ABC-61DD-4FF4-B905-0E8C3991372DQ36644765-F24F35CD-AAEB-4366-BAEE-2022E4038025Q36898678-BEAAB40E-5DCF-45D7-BD9B-C0893E5D8828Q37038270-E4B349E2-A958-4A0E-AF76-A30388F1AED8Q37193141-55D94691-5CB9-4CAB-BBD0-BA0C7E8DB7B9Q37263818-F29223E1-0063-4FF5-BB3B-7F9E24415A03Q37575742-89CAE3E1-80B3-4ACD-A737-0671C4769271Q38712611-86A3A431-E841-4243-8AFF-C54FF1616C62Q38870452-C5E6ABF3-2FEF-4545-A446-793FDE5408BCQ38905356-889D6D01-95C0-4A48-9216-25A31958650CQ42712939-32FE8FB4-5C87-422E-9A46-5040682716CEQ46405195-AA499857-4C66-49EA-B0EA-27633DFC2D08Q55449589-6A19768F-DF7C-4076-96FA-391CBC43B871Q56354961-9F3539A1-1B3B-4535-9FDC-B47656C3A8E8Q56421802-69676562-F494-498B-A43F-3CFD55B7CC05
P2860
Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@ast
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@en
type
label
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@ast
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@en
prefLabel
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@ast
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Population pharmacokinetics of ...... m falciparum malaria in Uganda
@en
P2093
Eleanor Turyakira
Mehul Dhorda
Niklas Lindegardh
Nitra Nuengchamnong
Patrice Piola
Sulaiman Muwanga
P2860
P2888
P356
10.1186/1475-2875-11-293
P50
P577
2012-08-22T00:00:00Z
P5875
P6179
1019974843